Jasmine H. Wong

Jasmine H. Wong

Auto-generated profile, based on publicly available information

Jasmine H. Wong

Georgetown University School of Medicine , Washington, DC

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2023 in Archives of Dermatological Research
Verified
Journal Article
Closed access
PDF file
EKEmily Y. Kim
Emily Y. Kim
JWJasmine H. Wong
Jasmine H. Wong
AHAamir Hussain
Aamir Hussain
Khachemoune AmorKhachemoune Amor
Khachemoune Amor

7 July 2024 in Lasers in Surgery and Medicine
Verified
Journal Article
Open access
VSVictoria Slavinsky
Victoria Slavinsky
JWJasmine H. Wong
Jasmine H. Wong
BCBonnie C. Carney
Bonnie C. Carney
DLDavon T. Lee
Davon T. Lee
RARebekah Allely
Rebekah Allely
TTTaryn Elise Travis
Taryn Elise Travis
Objectives: Fractional ablative CO2 laser (FLSR) is used to treat hypertrophic scars (HTSs) resulting from burn injuries, which are characterized by factors, such as erythema, contracture, thickness, and symptoms of pain and itch. Traditionally, waiting a year after injury for scar maturation before starting laser treatment has been recommended; however, the potential benefits of earlier intervention have gained popularity. Still, the optimal timing for beginning laser intervention in patients with HTSs remains uncertain. This study aims to evaluate the ideal timing for the initiation of FLSR for HTSs using several qualitative and quantitative assessment measures. It was hypothesized that early intervention would lead to similar improvement trends as later intervention, however, would be more ideal due to the shortened time without symptom relief for patients.Methods: Patients who received three or more laser treatment sessions and completed both pre‐ and posttreatment evaluations were included in this analysis (n = 69). FLSR treatment was administered at 4–8‐week intervals. Patients starting treatment before 6 months after injury were classified as the early‐stage intervention group and those beginning treatment at 6–12 months after injury were classified as the late‐stage intervention group. Demographic data, including the age of patients at the time of first treatment, age of scars at the time of first treatment, biological sex, ethnicity, Fitzpatrick skin type, and use of laser‐assisted drug delivery, were collected by retrospective chart review. Patients were evaluated on six subjective scales and objectively for scar stiffness with durometry. For all scales, higher scores indicate worse scars. A two‐way ANOVA, Student's t‐test, and Mann–Whitney U‐test were used to compare scores from the pre‐ to posttreatment evaluations.Results: There were no significant differences between the groups for any of the demographic or scar‐specific variables; thus, differences in outcome can be attributed to the timing of intervention. Both groups demonstrated an improvement in scars with treatment over time (p < 0.05). Both early‐ and middle‐stage initiation showed scar symptom improvement in five out of six scales. In the late‐stage intervention, the Patient and Observer Scar Assessment Scale‐Patient average score did not show improvement. In the early‐stage intervention, the Vancouver Scar Scale total did not show improvement. Quantitative evaluation of scar stiffness by durometry did not show symptom improvement in either group. The Scar Comparison Scale demonstrated the greatest improvement across groups.Conclusion: Laser treatment led to scar improvement in at least one scale at each stage of initiation. Both intervention timelines resulted in equivalent outcomes, and early intervention should be considered when initiating FLSR treatment in burn scars to alleviate symptoms earlier.

11 March 2025 in Journal of Burn Care & Research
Verified
Journal Article
Closed access
CDCameron D'Orio
Cameron D'Orio
BCBonnie C. Carney
Bonnie C. Carney
JWJasmine H Wong
Jasmine H Wong
AGAngela Golding
Angela Golding
ARAlison Ross
Alison Ross
TTTaryn Elise Travis
Taryn Elise Travis
Hypertrophic scar (HTS) remains a comorbidity of burn injury, often requiring split-thickness skin grafting (STSG) and resulting in symptomatic HTS at grafted sites and STSG donor sites (DS). Literature supports the use of ablative fractional CO2 laser (FLSR) to treat HTS, however many trials lack control sites and tissue-level examinations. Given the widespread adoption of FLSR for HTS, delegation of non-treated scar sites for the sake of randomized controlled trials (RCT) is troubling for many clinicians. We trialed using STSG DS scars for randomization rather than withholding FLSR from HTS at grafted sites. Patients (n = 20) were treated for DS scar with FLSR. DS scars were randomized and treated with either 6 FLSR treatments, follow-ups, and standard of care (SOC) or SOC only. Prior to treatment, DS skin and normal skin (NS) were evaluated for trans-epidermal water loss (TEWL), melanin index (MI), elasticity, and erythema. Serial biopsies were analyzed for epidermal thickness, rete ridge ratio (RRR), and papillary dermal cellularity. All sites, including a separate burn scar (BS) site, were evaluated using the patient and observer scar assessment scale (POSAS) -observer (-O), -patient (-P), Vancouver Scar Scale (VSS), and an institutional Scar Comparison Scale (SCS). Prior to treatment, the DS control (DS C), DS treated (DS T), and BS sites were hyperpigmented compared to normal skin. BS was less elastic than all other sites and had increased TEWL compared to normal skin. DS skin had increased cellularity, decreased rete ridge ratios, and increased epidermal thickness compared to NS. Clinician observers and patients perceived the BS site as more severe versus DS skin through the POSAS-O, POSAS-P, and VSS. Over time, DS C and DS T sites were not different in TEWL, elasticity, erythema, MI, cellularity, RRR, epidermal thickness, POSAS-O scores, POSAS-P scores, VSS scores, or SCS scores. Over time, burn scar did not change in TEWL, elasticity, erythema, MI, POSAS-O scores, POSAS-P scores, and VSS scores. Decreased SCS scores within the DS C, DS T, and BS sites indicated patient-perceived improvement in all scars throughout the study time course. NS and DS skin possess inherent physiological differences, though not to the degree of burn scars vs. NS. FLSR may not alter the rate of maturation and remodeling of DS skin compared to current SOC. While improvement in scar assessment was observed in laser-treated BS HTS, no specific control for these sites was analyzed. Due to differences in the pathophysiology of HTS formation at grafted and donor sites, the STSG DS may not be an adequate substitute for BS HTS when designing RCTs to evaluate the effect of FLSR. Prior studies evaluating the use of FLSR in burn-related HTS consist of low-powered clinical trials or case studies without control sites or tissue-level examinations, prompting the design of an RCT in DS scars. However, this scar type may not be suitable for this study design. Future work should extend to extra-cellular matrix morphology and transcriptomics of donor site and burn scar healing to better understand the effects of laser treatment.

23 September 2026 in JAAD Case Reports
Verified
Journal Article
Open access
JWJasmine H. Wong
Jasmine H. Wong
SPShrina Pandey
Shrina Pandey
GTGiovanna Tarricone
Giovanna Tarricone
JLJinyu Lu
Jinyu Lu
HZHatice B. Zengin
Hatice B. Zengin
BMBeth N. McLellan
Beth N. McLellan